Tumors in Field of View
| Patient no. | Localization | No. of tumors | Volume (cm3) | Tumor PD-L1 expression from IHC | Total PD-L1 in slide (%) | Model preference AIC | VT (mL⋅cm−3) | Vb (%) |
| 2 | Lung RLL | 1 | 77.7 | + (90%) | 25 | STR | 4.0 | 10 |
| 2 | LN 10R | 2 | 4.1 | NA | STR | 4.1 | 31 | |
| 2 | LN 4R | 3 | 5.7 | NA | STR | 4.8 | 14 | |
| 2 | Lung LLL | 4 | 86.0 | + (95%) | 64 | STR | 2.5 | 17 |
| 3 | Lung LLL | 1 | 59.1 | − (0%) | 2 | TTI | 0.6 | 17 |
| 6 | Lung RUL | 1 | 2.3 | NA | STR | 0.7 | 8 | |
| 7 | LN AXIL 1 | 1 | 6.4 | NA | STR | 0.7 | 7 | |
| 7 | LN N7 | 2 | 24.7 | NA | TTI | 2.3 | 20 | |
| 7 | LN AXIL 2 | 3 | 14.5 | − (0%) | 3 | STR | 0.9 | 10 |
| 8 | Lung RUL | 1 | 6.4 | NA | STR | 0.6 | 11 | |
| 8 | Humerus | 2 | 18.0 | NA | TTI | 0.5 | 7 | |
| 9 | Lung RUL | 1 | 68.5 | − (0%) | 5 | STR | 0.9 | 22 |
| 11 | Lung hilar mass | 2 | 6.5 | NA | STR | 1.5 | 22 | |
| 12 | Lung LLL | 1 | 2.4 | + (10%) | 10 | TTI | 1.3 | 16 |
| 12 | LN 10 L | 2 | 1.2 | NA | TTI | 1.4 | 34 | |
| 12 | LN 11 L | 3 | 2.7 | NA | STR | 2.3 | 34 | |
| 13 | Pancreas | 1 | 8.8 | NA | TTI | 0.4 | 11 | |
| 13 | Pancreas | 2 | 26.6 | NA | TTI | 0.5 | 15 |
RLL = right upper lobe; LN = lymph node; LLL = left lower lobe; RUL = right upper lobe; AXIL = axillary; IHC = immunohistochemistry; NA = not applicable; AIC = Akaike information criterion; STR = single-tissue reversible; TTI = 2-tissue irreversible; Vb = blood volume fraction.